期刊文献+

子宫颈癌综合治疗后腹主动脉旁合并或不合并锁骨上淋巴结转移的临床分析 被引量:1

Clinical analysis of paraaortic combined with or not supraclavicular lymph node metastasis in patients with cervical cancer after combined treatment
原文传递
导出
摘要 目的分析子宫颈癌综合治疗后出现腹主动脉旁合并或不合并锁骨上淋巴结转移的临床特征、治疗和预后。方法对20例出现腹主动脉旁合并或不合并锁骨上淋巴结转移的子宫颈癌患者的临床资料进行回顾性分析。结果20例患者初诊时均行以下一项或二项检查:磁共振成像(MRI)、计算机层析成像(CT)、单光子发射型计算机断层显像(SPECT),未发现远处淋巴结转移。在手术、放化疗等综合治疗后,于观察期2年内,最短2个月开始出现转移,其中1例黏液腺癌为治疗中进展,开始治疗到死亡时间为6个月。15例为单纯腹主动脉旁淋巴结转移,其中4例为腹主动脉旁淋巴结放疗后3~6个月又出现左锁骨上淋巴结转移。4例为腹主动脉旁及左锁骨上淋巴结同时发现转移。20例病例中,复发放弃治疗的7例均在2年内死亡,中位生存时间为7.50个月;复发有治疗的13例,中位生存时间18.98个月,两者差异有统计学意义(X^2=7.23,P〈0.01)。结论子宫颈癌综合治疗后出现腹主动脉旁合并或不合并锁骨上淋巴结转移患者经再治疗可明显延长生存期,有积极治疗意义。 Objective To analysis the clinical characteristics, treatment and prognosis for patients with cervical cancer with lymph lode of paraaortic and/or supraclavicular metastasis after combined treatment in two years. Methods Data of 20 patients with lymph lode of paraaortic and/or supraclavicular metastasis of cervical cancer were analyzed retrospectively. Results There was no evidence of lymph node of paraaortic and supraclavicular metastasis before the first combined treatments according to the MRI/CT/SPECT scans in these 20 patients. However, lymph lode of paraaortic and/or supraclavicular metastasis were seen in two years after treatments, the shortest is two months. One patient was progressing during treatment whose pathologic diagnosis is mucinous adenocarcinoma, died in 6 months from treatment start. There was only paraaortic metastasis in 15 patients, among these, 4 patients were found lymph lode of left supraclavical metastasis after retreatments in 3-6 months. Both paraaortic and left-supraclavical lymph node metastasis in 4 cases. Among these 20 cases, recurrence and to give up treatment, whose median survival time is 7.50 months, recurrence and to gain treatment, whose median survival time is 18.98 months, there was significant difference (X^2=7.23, P〈0.01). Conclusion Patients with cervical cancer with lymph lode of paraaortic and/or supraclavicular metastasis after combined treatment will obviously extend survival time after retretments, which has positive therapy significance.
出处 《肿瘤研究与临床》 CAS 2011年第5期328-330,334,共4页 Cancer Research and Clinic
关键词 子宫颈肿瘤 淋巴转移 治疗 Uterine cervical neoplasms Lymphatic metastasis Therapy
  • 相关文献

参考文献10

  • 1章文华.晚期及复发性子宫颈癌//连利娟.林巧稚妇科肿瘤学.4版.北京:人民卫生出版社,2006:394.
  • 2余健,张国楠,谢瑞梦,樊英,田昌英.宫颈癌术后复发60例临床分析[J].中国实用妇科与产科杂志,2005,21(3):161-162. 被引量:10
  • 3Tran BN, Grigsby PW, Dehdashti F, et al. Occult supraclavicular lymph node metastasis identified by FDG-PET in patients with carcinoma of the uterine cervix. Gynecol Oncol, 2003, 90: 572-576.
  • 4Boran N, Kayikcioglu F, Tulunay G, et al. Scalene lymph node dissection in locally advanced cervical carcinoma: is it reasonable or unnecessary? Tumori, 2003, 89: 173-175.
  • 5Ryu SY, Kim MH, Choi SC, et al. Detection of early recurrence with 18F-FDG PET in patients with cervical cancer. J Nucl Med, 2003, 44: 347-352.
  • 6于金明,范廷勇,邢力刚,李建彬,付政,孙晓蓉.^(18)F FDG PET/CT对恶性肿瘤放射治疗方法的影响[J].中国肿瘤临床,2005,32(12):670-673. 被引量:14
  • 7刘炽明,吴令英.子宫颈浸润癌的诊断、分期及影响预后因素//连利娟.林巧稚妇科肿瘤学.4版.北京:人民卫生出版社,2006:342-353.
  • 8Hong JH, Tsai CS, Lai CH, et al. Recurrent squamous cell carcinoma of cervix after definitive radiotherapy.Int J Radiat Oneol Biol Phys, 2004, 60: 249-257.
  • 9Miller TR, Pinkus E, Dehdashti F, et al. Improved prognostic value of 18F-FDG PET using a simple visual analysis of tumor characteristics in patients with cervical cancer. J Nucl Med, 2003, 44: 192-197.
  • 10Grigsby PW, Siegel BA, Dehdashti F, et al. Posttherapy surveillance monitoring of cervical cancer by FDG-PET. Int J Radiat Oncol Biol Phys, 2003, 55: 907-913.

二级参考文献14

  • 1Samlal RK,Velden JVD,Kate FWT,et al.Surgical pathologic factors that predict recurrence in stage Ib and IIa cervical carcinoma patients with negative pelvic lymph nodes.Cancer,1997,80(7):1234-1240.
  • 2Sedlis A,Bundy B,Rotman M,et al.A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage Ib carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy:a Gynecologic Oncology Group study.Gynecol Oncol,1999,73(2):177-183.
  • 3Schorge J,Molpus K,Koelliker D,et al.Stage Ib and IIa cervical cancer with negative lymph nodes:the role of adjuvant radiotherapy after radical hysterectomy.Gynecol Oncol,1997,66(1):31-33.
  • 4Goerres GW, von Schulthess GK, Steinert HC, Why most PET of lung and head-and-neck cancer will be PET/CT [J]. J Nucl Med, 2004, 45(Suppll):66S-71S.
  • 5Pelosi E, Messa C, Sironi S, et al. Value of integrated PET/CT for lesion localisadon in cancer patients: a comparative study[J].Eur J Nud Med Mol Imaging, 2004, 31(7):932-939.
  • 6Schoder H, Larson SM, Yetmg HW, PET/CT in oncology: integration into clinical management of lymphoma, melanoma, and gastrointestinal malignancies[J]. J Nucl Med, 2004, 45 Suppll:72S-81S.
  • 7Wahl RL, Why nearly all PET of abdominal and pelvic cancers will be performed as PET/CT [J]. J Nucl Med, 2004, 45 Suppll:82S-95S.
  • 8Kluetz PG, Meltzer CC, Villemagne VL, et al. Combined PET/CT imaging in oncology impact on patient management [J], Clin Positron Imaging, 2000, 3(6): 223-230.
  • 9Dizendorf EV, Baumert BG, von Schulthess GK, et al, Impact of whole-body 18F-FDG PET on staging and managing patients for radiation therapy[J]. J Nucl Med, 2003, 44(1):24-29.
  • 10Ciernik IF, Dizendorf E, Baumert BG, et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study[J]. IntJ Radiat Oncol Biol Phys, 2003, 57(3):853-863.

共引文献21

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部